Asian Pac J Cancer Prev, 15 (15), [6363][6364][6365][6366][6367] Introduction Gastric cancer remains a major global problem. In 2008, 989,600 new stomach cancer cases and 738,000 deaths occurred, accounting for 8% of the total cases and 10% of total deaths, respectively (Jemal et al., 2011) . Notwithstanding the global declining incidence of gastric cancer, mortality is continuously rising in Asian countries (Hu et al., 2004) . Surgery is considered as the gold standard for localized gastric cancer, but most cases are diagnosed at an advanced stage. The five-year survival rate of patients with advanced gastric cancer for surgical treatment is less than 40% (Rasul et al., 2012) . Recent primary prevention strategies for gastric cancer focus on behavior modification, including the eradication of Helicobacter pylori, reduction of salt intake, increase in food containing protective factors (fruit,vegetables, soybean products, non-fermented soy-foods,whole-grain) and vitamin C consumption, abolition of smoking, and chemoprevention (Tsugane et al., 2004 
Introduction
Gastric cancer remains a major global problem. In 2008, 989,600 new stomach cancer cases and 738,000 deaths occurred, accounting for 8% of the total cases and 10% of total deaths, respectively (Jemal et al., 2011) . Notwithstanding the global declining incidence of gastric cancer, mortality is continuously rising in Asian countries (Hu et al., 2004) . Surgery is considered as the gold standard for localized gastric cancer, but most cases are diagnosed at an advanced stage. The five-year survival rate of patients with advanced gastric cancer for surgical treatment is less than 40% (Rasul et al., 2012) . Fuccio et al., 2010; Li et al., 2012; Priyadarsini et al., 2012; Zullo et al., 2012) .
Cancer chemoprevention is defined as the use of natural, synthetic, or biologic chemical agents to reverse, suppress, or prevent carcinogenic progression to invasive cancer. The success of several recent clinical trials in terms of cancer prevention among high-risk populations suggests that chemoprevention is a rational and effective strategy (Tsao et al., 2004) . Chemoprevention has received considerable attention as a potential means to control the incidence of gastric cancer (Ganapathy et al., 2008; Lu et al., 2008; Xu et al., 2011; Bilici et al., 2012) .
Actinidia valvata Dunn (AVD), which is affiliated with the genus Actinidia, is a shrub that mainly grows in eastern China. Total saponin from the root of AVD inhibits the growth of several tumor cell lines in vitro and vivo Zheng et al., 2012) . Corosolic acid, a natural triterpenoid derived from many traditional Chinese medicinal herbs, such as AVD and apple pomace, reportedly possesses cytotoxic activity against a variety of cell lines, including lung, cervix, gastric, ovarian, and colon cells (Xu et al., 2009; Lee et al., 2010; Fujiwara et al., 2013; Nho et al., 2013; Sung et al., 2014) . Extract from the root of AVD, also known as Maorenshen in traditional Chinese medicine, has long been used to treat lung carcinoma, hepatoma, and myeloma .
This study evaluates the use of AVD extract to prevent gastric cancer induced by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) in rats. In addition, cell apoptosis and proliferation in the stomach epithelium is measured to understand the functional mechanism of AVD extract.
Materials and Methods

Animals
Seventy-five male Wistar rats aged four weeks to six weeks with body weight of ~50 g were obtained from the Laboratory Animal Center of Nanjing Medical University. Three to four rats were kept in each metal cage at 22±2°C temperature, 55%±5% relative humidity, and 12h lightdark cycle. Rats were fed with regular chow pellets and water ad libitum. After a one-week acclimation period, the rats were used in the experiments. The study protocol was approved by the Animal Ethics Committee of Nanjing Medical University.
Chemicals
MNNG was purchased from Tokyo Chemical Industry Co. (Tokyo, Japan). AVDs (Anhui, China) were powdered and refluxed thrice with 80% alcohol for 1.5 h for each time, as described by Zheng et al. (2012) The extract solutions were evaporated to dryness under reduced pressure and crushed into brown powders. The yield of AVD alcohol extract was 9%. This process was supported by Jiangsu Institute of Material Medical.
Study design
Rats were classified into five groups with 15 rats in each group.
Group I: control group with distilled drinking water and given corresponding normal saline daily by oral gavage.
Groups II and III: treated with 0.1g/L of MNNG with distilled water prepared thrice per week for 24 weeks according to the protocol described in previous reports (Hu et al., 2004; Okazaki et al., 2006; Tomita et al., 2008) . The MNNG solution was protected from light and given ad libitum to rats through drinking water. At the first six weeks, 1 mL of 10% sodium chloride was given to rats by oral gavage to enhance gastric cancer development (Tatematsu et al., 1975) . From the 25th week to the 36th week, animals in Group II were treated in a manner similar to those in Group I, whereas rats in Group III were given AVD extract (0.24g/kg body weight daily, dissolved in distilled water by oral gavage). Drug doses between rats and humans were calculated on the basis of body surface area. The regular dosage of AVD for adults was 30g/day according to the following formula: 30* 0.018/0.2=2.7g/ kg; 2.7 * 9%=0.24g/kg/day.
Group IV: treated in a manner similar to Group II for 24 weeks, thereafter treated with AVD extract in a manner similar to group III from the first week to the 36 th week. Group V: control animals treated with AVD extract alone (similar to animals in Group IV) for 36 weeks.
During the study, general conditions were applied to all rats. The body weights were recorded weekly. Rats that died before the end of the experiment were autopsied to determine the cause of death and to assess the presence of gastric tumors. At the end of the 36-week experiment, all animals were sacrificed by cervical dislocation after overnight fasting. The stomach tissues were subdivided and underwent various processes for distribution to each experiment.
Histopathology
Tissues were fixed in 10% neutral buffered formalin, embedded in paraffin, sectioned, mounted on polylysinecoated slides, and stained with hematoxylin and eosin. Histological analysis was performed in duplicate by two different pathologists who were blinded to the study design. The defining characteristics for atypical hyperplasia and adenocarcinoma were adapted from the existing literature (Ikezaki et al., 1996) .
Immunohistochemistry
Immunohistochemistry expressions of Bax, Bcl-2, cyclinD1, and Caspase-3 were analyzed by using the streptavidin-peroxidase method. After deparaffinization, 5μm thick sections were rehydrated in graded alcohol and then washed with water. The slides were placed in a microwave and incubated in citrate buffer (pH 6.0). Antigen retrieval was performed by steam heating for 10 min. The sections were naturally cooled and rinsed with phosphate buffered saline (PBS, pH 7.4), after which they were treated with 3% H2O2 for 20 min to inhibit the endogenous peroxidase activity. After blocking with normal goat serum for 20 min for nonspecific antibody binding, the sections were treated overnight at 4°C in a humid chamber with primary antibodies for Bcl-2, Bax, Caspase-3, and cyclinD1, as well as rabbit polyclonal antibody (Santa Cruz, CA, USA). The slides were washed with PBS and then incubated with biotin-labeled goat secondary antibody (1:100 dilution). Then samples were incubated with peroxidase-conjugated streptavidin for 20 min at room temperature (RT). The reaction was developed by using 0.024% diaminobenzidine (Sigma, USA) solution and 0.16% hydrogen peroxide. Finally, the slides were dehydrated, cleared, and counter-stained with Harris' hematoxylin. As a negative control, nonimmunized rabbit serum was substituted for the primary antibody. The known positive gastric cancers were used as positive controls.
Image-Pro Plus 6.0 was used to analyze the immunohistochemical images. Accumulated integrated optical density was applied to determine the positive value of every image.
Western blot
Proteins were separated on 12% sodium dodecyl sulfate-polyacrylamide gels at 80 V. The gels were then transferred onto a poly-vinylidine difluoride membrane, incubated in a blocking solution containing 5% milk proteins in Tris-buffered saline (TBST) with Tween 20 (TBST: 10 mM Tris-HCl, 150 mM NaCl, and 0.1% Tween 20, pH 7.6) for 2h at RT and then probed overnight at 4°C with primary antibodies (Bcl-2, Bax, cyclinD1, Santa Cruz, CA, USA). The blots were washed thrice with TBST and incubated for 2h at RT with horseradish peroxidaseconjugated donkey anti-rabbit IgG (Beyotime Technology) and then again washed thrice in TBST. The membrane was incubated with ECL substrate solution for 5 min according to manufacturer's instructions and visualized with autoradiography film. The imaging program Quantity One (Bio-Rad) was used for quantification. Human β-actin (cell signaling technology, MA, USA) was used as the control of protein integrity.
Statistical analysis
The data were presented as means and standard deviations from triplicate experiments performed in parallel, unless otherwise indicated. Data statistical analyses were performed with SPSS software (Version 13.0, SPSS Inc. NC, USA). Differences among groups were tested by one-way ANOVA. Groups were compared by using unpaired Student's t test. A value of p<0.05 was considered to be statistically significant.
Results
General observation
Seventeen deaths occurred during the study period one in Group I, seven in Group II, five in Group III, and four in Group IV. Three animals died of lung congestion. Twelve rats died of gastric cancer. One rat died of esophageal cancer and one, of small bowel cancer. The causes of death are listed in Table 1 . Body weights of Group II were significantly lower than those of the other groups (p<0.05). However, no significant difference was observed among other groups during the whole study period (p>0.05) ( Figure. 1) .
Twenty animals developed gastric cancer at the end of this study: none in Group I, 11 in Group II, five in Group III, and four in Group IV (Table 1 ). All gastric tumors were histologically confirmed to be adenocarcinomas. Tumors usually occurred near the lesser curvature of the gastric antrum, which was similar to human gastric cancer.
Immunohistochemical and Western blot data for markers of apoptosis and proliferation in stomach tissue
Bax and Caspase-3 expressions were significantly lower, whereas Bcl-2 and cyclinD1 expressions were significantly higher in MNNG-treated rats (Group II) than those in other groups. Upon pre-and post-treatment with AVD extract (Groups III and IV) Bax and Caspase-3 increased, whereas Bcl-2 and cyclinD1 decreased with a significance of p<0.05 in Group II. The administration of AVD extract alone did not affect the expression of the analyzed markers when compared with the control (Group I) ( Figure. 2).
Discussion
Gastric cancer remains one of the most frequent gastrointestinal cancers. However, WHO recognized that most of cancers and deaths can be prevented. Traditional medicine and therapies can be considered in research on cancer prevention, early detection, and management strategies (World Health Organization, 2005) . AVD has 
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been widely used to treat cancers. However, recent reports on experimental data regarding specific agents that prevent or retard gastric carcinogenesis are limited. In this study, the protective action of AVD extract against MMNG-induced gastric carcinogenesis has been discussed. With the use 0.24 g/kg/day of AVD extract, an approximately 40% reduction in tumor incidence was observed. However, no significant difference was observed between the pre-treatment group (Group IV) and the posttreatment group (Group III). To our knowledge, this study is the first to report an inhibitory effect of AVD extract on MNNG-induced gastric carcinogenesis.
Hyperproliferation and apoptosis evasion are interlinked relative to cancer cell survival. The potential mechanism of apoptosis avoidance for gastric carcinogenesis has been related to the increase in Bcl-2 to Bax ratio with decreased expression of Caspase-3 (Manikandan et al., 2008) . According to a previous report, cyclinD1 expression is an early event in human gastric carcinogenesis and may serve as one of the early molecular markers for gastric cancers (Motohashi et al., 2011) . In this study, high Bcl-2 and cyclinD1 expressions and low Bax and Caspase-3 expressions were observed in the pyloric gastric epithelium of the MNNG-treated group. AVD extract acted as a suppressing agent by inhibiting cell proliferation and inducing apoptosis to reduce the incidence of gastric cancer. The results provide evidence for the differential sensitivities of tumor and normal cells to apoptosis induction by AVD extract. No significant changes were observed in the expression of apoptosis-related proteins in animals administered with AVD extract alone compared with control animals. This finding indicates that AVD extract drives carcinogenexposed cells to apoptosis while protecting normal cells.
In summary, we demonstrated that the administration of AVD extract can suppress MNNG-induced gastrointestinal cancer in rats. AVD extract can be considered as a promising chemopreventive agent against the occurrence of human gastric cancers. The possible mechanism might be related to the modulation of several key molecules that regulate cell growth.
